What is the appropriate evaluation and management for a child with unilateral (single‑sided) deafness?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Single-Sided Deafness: Evaluation and Management

All children with single-sided deafness (SSD) should be considered eligible for early intervention services and undergo comprehensive audiologic evaluation with ABR testing, medical evaluation including genetics consultation and otolaryngology assessment, and be offered amplification options with ongoing developmental monitoring, regardless of the unilateral nature of their hearing loss. 1

Diagnostic Evaluation

Audiologic Assessment

  • Confirm diagnosis with ABR testing as part of comprehensive audiologic evaluation for children under 3 years, even with unilateral loss 1
  • Perform behavioral audiometry appropriate to developmental age:
    • Visual reinforcement audiometry (6-24 months)
    • Play audiometry (24-48 months)
    • Conventional audiometry (≥4 years) 2
  • Include speech detection/recognition thresholds and speech understanding measures 2
  • Do not substitute tympanometry, pneumatic otoscopy, or caregiver judgment for formal hearing testing 2

Medical Workup

The following evaluations are mandatory 1:

  • Otolaryngology evaluation by physician knowledgeable in pediatric hearing loss
  • Genetics consultation offered to all families - genetic etiology is likely in most cases 3, 4
  • Ophthalmology examination by experienced pediatric ophthalmologist
  • Imaging studies to identify anatomic abnormalities (cochlear nerve deficiency is found in 44% of congenital SSD cases) 5
  • CMV testing if diagnosed early, as congenital CMV accounts for 6.8% of pediatric SSD 5

Etiologic Investigation

Target the history and examination toward 4:

  • Three-generation pedigree with attention to consanguinity and inheritance patterns
  • Ethnicity and country of origin
  • Audiometric characteristics in affected family members
  • Evidence of vestibular dysfunction
  • Syndromic features (visual abnormalities, cardiac issues, renal problems, pigmentary changes)
  • Environmental exposures (aminoglycosides, noise, prematurity)

Management Approach

Early Intervention Services

Initiate intervention within 2 days of diagnosis confirmation and begin services no later than 6 months of age 1. This is critical because:

  • 46% of children with SSD show delays in receptive language skills
  • 48% demonstrate delays in expressive language skills 6
  • Deficits can parallel those seen in bilateral hearing loss despite having one normal ear 7
  • Early intervention within the sensitive period of auditory development may prevent cognitive, academic, and psychosocial barriers 7

Intervention Team

Services must be provided by professionals with specific expertise in hearing loss 1:

  • Educators of the deaf
  • Speech-language pathologists specializing in hearing loss
  • Audiologists
  • Both home-based and center-based options should be offered 1

Amplification Options

Assess appropriateness of hearing aid fitting for all children with SSD 1. The decision depends on degree of residual hearing:

Conventional hearing aids:

  • May benefit some children depending on residual hearing
  • Trial fitting recommended to determine benefit 1

Bone conduction devices:

  • Demonstrate benefits in sound perception and quality of life 8
  • More readily accepted than CROS systems

Contralateral routing of signals (CROS):

  • Not recommended for pediatric unilateral hearing loss 1

Cochlear implantation:

  • Emerging as viable option for congenital SSD 9, 10
  • Goals include providing bilateral input and developing binaural hearing 9
  • Significant improvements demonstrated in:
    • Speech in noise (SNR improvement from 1.08 dB to -1.67 dB, p=0.0021) 11
    • Sound localization (RMS improvement from 69.76° to 52.38°, p=0.0040) 11
    • Subjective quality of life measures 11
  • Best outcomes with early implantation (mean age 2.6 years in successful cases) 11
  • Requires specialized candidacy evaluation and follow-up protocols 9

Critical Caveat on Amplification

Be prepared for high rates of device discontinuation - 84.7% of pediatric SSD patients report either discontinued use or <6 hours daily use 5. Common reasons include:

  • Vibratory sensation with devices
  • Having "good enough" hearing in one ear
  • Lack of perceived benefit

This underscores the importance of thorough counseling about realistic expectations and the need for ongoing support.

Ongoing Surveillance

Developmental Monitoring

Regular assessment is essential because intervention needs may be subtle 1:

  • Standardized developmental screening at 9,18, and 24-30 months using validated tools 1
  • Speech-language evaluation if concerns arise or screening failures occur 1
  • Monitor for:
    • Language development delays
    • Academic difficulties
    • Social-emotional challenges
    • Patient fatigue and parental stress 7

Audiologic Follow-up

  • Regular hearing assessments in both ears
  • Aggressive management of otitis media with effusion - OME compounds the hearing deficit and negatively affects amplification fitting 1
  • Never delay amplification fitting for OME resolution; treat OME promptly instead 1

Family-Centered Counseling

Provide families with 1:

  • Unbiased information about all communication options and hearing technologies
  • Opportunities to interact with other families of children with hearing loss
  • Access to deaf and hard-of-hearing adults and children
  • Information about professional and consumer organizations
  • Culturally sensitive communication in understandable format
  • Recognition that some families view deafness as a cultural/linguistic identity rather than pathology 3

Common Pitfalls to Avoid

  1. Assuming one normal ear is sufficient - Historical views are outdated; SSD significantly impacts development 7, 6

  2. Missing the diagnosis - 23.9% of congenital SSD cases pass newborn hearing screening 5

  3. Delaying intervention - The sensitive period for auditory development is time-limited 7

  4. Inadequate follow-up - Loss to follow-up occurs in 39.8% of cases 5; establish robust tracking systems

  5. Overlooking comorbidities - Cochlear nerve deficiency, syndromic features, and progressive conditions require identification 5, 4

  6. Failing to address parental guilt and anxiety - Genetic counseling can relieve guilt and provide psychological benefit 3

References

Guideline

clinical practice guideline: otitis media with effusion.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2004

Research

Therapeutic challenges and clinical characteristics of single-sided deafness in children.

International journal of pediatric otorhinolaryngology, 2020

Research

Assessment of language development in children with prelingual single-sided deafness.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2026

Research

Impact of unilateral hearing loss in early development.

Current opinion in otolaryngology & head and neck surgery, 2022

Research

Pediatric Single-Sided Deafness.

Otolaryngologic clinics of North America, 2022

Research

Long-term Outcome After Cochlear Implantation in Children With Single-sided Deafness.

Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.